194 related articles for article (PubMed ID: 34123875)
1. Rapamycin Improves the Response of Effector and Memory CD8
Moraschi BF; Noronha IH; Ferreira CP; Cariste LM; Monteiro CB; Denapoli P; Vrechi T; Pereira GJS; Gazzinelli RT; Lannes-Vieira J; Rodrigues MM; Bortoluci KR; Vasconcelos JRC
Front Cell Infect Microbiol; 2021; 11():676183. PubMed ID: 34123875
[TBL] [Abstract][Full Text] [Related]
2. Heterologous plasmid DNA prime-recombinant human adenovirus 5 boost vaccination generates a stable pool of protective long-lived CD8(+) T effector memory cells specific for a human parasite, Trypanosoma cruzi.
Rigato PO; de Alencar BC; de Vasconcelos JR; Dominguez MR; Araújo AF; Machado AV; Gazzinelli RT; Bruna-Romero O; Rodrigues MM
Infect Immun; 2011 May; 79(5):2120-30. PubMed ID: 21357719
[TBL] [Abstract][Full Text] [Related]
3. Perforin and gamma interferon expression are required for CD4+ and CD8+ T-cell-dependent protective immunity against a human parasite, Trypanosoma cruzi, elicited by heterologous plasmid DNA prime-recombinant adenovirus 5 boost vaccination.
de Alencar BC; Persechini PM; Haolla FA; de Oliveira G; Silverio JC; Lannes-Vieira J; Machado AV; Gazzinelli RT; Bruna-Romero O; Rodrigues MM
Infect Immun; 2009 Oct; 77(10):4383-95. PubMed ID: 19651871
[TBL] [Abstract][Full Text] [Related]
4. Vaccination using recombinants influenza and adenoviruses encoding amastigote surface protein-2 are highly effective on protection against Trypanosoma cruzi infection.
Barbosa RP; Filho BG; Dos Santos LI; Junior PA; Marques PE; Pereira RV; Cara DC; Bruña-Romero O; Rodrigues MM; Gazzinelli RT; Machado AV
PLoS One; 2013; 8(4):e61795. PubMed ID: 23637908
[TBL] [Abstract][Full Text] [Related]
5. CXCR3 chemokine receptor guides Trypanosoma cruzi-specific T-cells triggered by DNA/adenovirus ASP2 vaccine to heart tissue after challenge.
Pontes Ferreira C; Cariste LM; Ferri Moraschi B; Ferrarini Zanetti B; Won Han S; Araki Ribeiro D; Vieira Machado A; Lannes-Vieira J; Gazzinelli RT; Vasconcelos JRC
PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007597. PubMed ID: 31356587
[TBL] [Abstract][Full Text] [Related]
6. A Two-Component DNA-Prime/Protein-Boost Vaccination Strategy for Eliciting Long-Term, Protective T Cell Immunity against Trypanosoma cruzi.
Gupta S; Garg NJ
PLoS Pathog; 2015 May; 11(5):e1004828. PubMed ID: 25951312
[TBL] [Abstract][Full Text] [Related]
7. Experimental Nanovaccine Offers Protection Against Repeat Exposures to
Chowdhury IH; Lokugamage N; Garg NJ
Front Immunol; 2020; 11():595039. PubMed ID: 33414785
[TBL] [Abstract][Full Text] [Related]
8. Delivery of antigenic candidates by a DNA/MVA heterologous approach elicits effector CD8(+)T cell mediated immunity against Trypanosoma cruzi.
Gupta S; Garg NJ
Vaccine; 2012 Nov; 30(50):7179-86. PubMed ID: 23079191
[TBL] [Abstract][Full Text] [Related]
9. A human type 5 adenovirus-based Trypanosoma cruzi therapeutic vaccine re-programs immune response and reverses chronic cardiomyopathy.
Pereira IR; Vilar-Pereira G; Marques V; da Silva AA; Caetano B; Moreira OC; Machado AV; Bruna-Romero O; Rodrigues MM; Gazzinelli RT; Lannes-Vieira J
PLoS Pathog; 2015 Jan; 11(1):e1004594. PubMed ID: 25617628
[TBL] [Abstract][Full Text] [Related]
10. Efficient protective immunity against Trypanosoma cruzi infection after nasal vaccination with recombinant Sendai virus vector expressing amastigote surface protein-2.
Duan X; Yonemitsu Y; Chou B; Yoshida K; Tanaka S; Hasegawa M; Tetsutani K; Ishida H; Himeno K; Hisaeda H
Vaccine; 2009 Oct; 27(44):6154-9. PubMed ID: 19712768
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus vector-induced CD8⁺ T effector memory cell differentiation and recirculation, but not proliferation, are important for protective immunity against experimental Trypanosoma cruzi Infection.
Vasconcelos JR; Dominguez MR; Neves RL; Ersching J; Araújo A; Santos LI; Virgilio FS; Machado AV; Bruna-Romero O; Gazzinelli RT; Rodrigues MM
Hum Gene Ther; 2014 Apr; 25(4):350-63. PubMed ID: 24568548
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic efficacy of TcVac2 against Trypanosoma cruzi in mice.
Gupta S; Garg NJ
PLoS Negl Trop Dis; 2010 Aug; 4(8):e797. PubMed ID: 20706586
[TBL] [Abstract][Full Text] [Related]
13. TcVac3 induced control of Trypanosoma cruzi infection and chronic myocarditis in mice.
Gupta S; Garg NJ
PLoS One; 2013; 8(3):e59434. PubMed ID: 23555672
[TBL] [Abstract][Full Text] [Related]
14.
Gupta S; Salgado-Jiménez B; Lokugamage N; Vázquez-Chagoyán JC; Garg NJ
Front Immunol; 2019; 10():1456. PubMed ID: 31293599
[No Abstract] [Full Text] [Related]
15. The Combined Deficiency of Immunoproteasome Subunits Affects Both the Magnitude and Quality of Pathogen- and Genetic Vaccination-Induced CD8+ T Cell Responses to the Human Protozoan Parasite Trypanosoma cruzi.
Ersching J; Vasconcelos JR; Ferreira CP; Caetano BC; Machado AV; Bruna-Romero O; Baron MA; Ferreira LR; Cunha-Neto E; Rock KL; Gazzinelli RT; Rodrigues MM
PLoS Pathog; 2016 Apr; 12(4):e1005593. PubMed ID: 27128676
[TBL] [Abstract][Full Text] [Related]
16. Critical contribution of immunoproteasomes in the induction of protective immunity against Trypanosoma cruzi in mice vaccinated with a plasmid encoding a CTL epitope fused to green fluorescence protein.
Chou B; Hisaeda H; Shen J; Duan X; Imai T; Tu L; Murata S; Tanaka K; Himeno K
Microbes Infect; 2008 Mar; 10(3):241-50. PubMed ID: 18321749
[TBL] [Abstract][Full Text] [Related]
17. Immunization With Lipopolysaccharide-Activated Dendritic Cells Generates a Specific CD8
Biscari L; Kaufman CD; Farré C; Huhn V; Pacini MF; Balbi CB; Gómez KA; Pérez AR; Alloatti A
Front Cell Infect Microbiol; 2022; 12():897133. PubMed ID: 35903201
[TBL] [Abstract][Full Text] [Related]
18. Quantitative and qualitative features of heterologous virus-vector-induced antigen-specific CD8+ T cells against Trypanosoma cruzi infection.
Takayama E; Ono T; Carnero E; Umemoto S; Yamaguchi Y; Kanayama A; Oguma T; Takashima Y; Tadakuma T; García-Sastre A; Miyahira Y
Int J Parasitol; 2010 Nov; 40(13):1549-61. PubMed ID: 20620143
[TBL] [Abstract][Full Text] [Related]
19. TcVac1 vaccine delivery by intradermal electroporation enhances vaccine induced immune protection against Trypanosoma cruzi infection in mice.
Hegazy-Hassan W; Zepeda-Escobar JA; Ochoa-García L; Contreras-Ortíz JME; Tenorio-Borroto E; Barbabosa-Pliego A; Aparicio-Burgos JE; Oros-Pantoja R; Rivas-Santiago B; Díaz-Albiter H; Garg NJ; Vázquez-Chagoyán JC
Vaccine; 2019 Jan; 37(2):248-257. PubMed ID: 30497833
[TBL] [Abstract][Full Text] [Related]
20. A DNA-priming protein-boosting regimen significantly improves type 1 immune response but not protective immunity to Trypanosoma cruzi infection in a highly susceptible mouse strain.
Vasconcelos JR; Boscardin SB; Hiyane MI; Kinoshita SS; Fujimura AE; Rodrigues MM
Immunol Cell Biol; 2003 Apr; 81(2):121-9. PubMed ID: 12631235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
